| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 7, 2018 | Sep 11, 2018 | Seres Therapeutics, Inc. | CEO | Sell | 51.3 | -1,810 | -0.84% | ✓ | $16.3K |
| Sep 5, 2018 | Sep 6, 2018 | Seres Therapeutics, Inc. | CEO | Sell | 32.5 | -12,518 | -5.48% | ✓ | $113.9K |
| Jul 11, 2018 | Jul 12, 2018 | Seres Therapeutics, Inc. | CEO | Sell | 53.8 | -1,010 | -0.44% | ✓ | $9.1K |
| Jul 6, 2018 | Jul 10, 2018 | Seres Therapeutics, Inc. | CEO | Sell | 35.0 | -32,336 | -4.51% | ✓ | $295.1K |
| Jun 28, 2018 | Jun 29, 2018 | Seres Therapeutics, Inc. | CEO | Sell | 32.5 | -26,056 | -5.40% | ✓ | $238.3K |
| Jun 25, 2018 | Jun 27, 2018 | Seres Therapeutics, Inc. | CEO | Sell | 26.3 | -64,967 | -8.66% | ✓ | $595K |
| Jun 20, 2018 | Jun 22, 2018 | Seres Therapeutics, Inc. | CEO | Sell | 7.5 | -85,536 | -26.38% | ✓ | $793.9K |
| May 9, 2018 | May 10, 2018 | Seres Therapeutics, Inc. | CEO | Sell | 56.3 | -233 | -0.07% | ✓ | $2.1K |
| Jul 27, 2016 | Jul 28, 2016 | Seres Therapeutics, Inc. | CEO | Sell | 20.0 | -20,000 | -9.82% | ✗ | $700K |
| Jul 5, 2016 | Jul 7, 2016 | Seres Therapeutics, Inc. | CEO | Sell | 17.5 | -88,211 | -10.36% | ✗ | $2.6M |
| Jul 1, 2016 | Jul 5, 2016 | Seres Therapeutics, Inc. | CEO | Sell | 17.5 | -56,789 | -23.61% | ✗ | $1.7M |
| Jun 2, 2016 | Jun 6, 2016 | Seres Therapeutics, Inc. | CEO | Sell | 17.5 | -74,049 | -28.73% | ✗ | $2.4M |
| Jun 1, 2016 | Jun 2, 2016 | Seres Therapeutics, Inc. | CEO | Sell | 17.5 | -70,951 | -27.86% | ✗ | $2.2M |
| May 24, 2016 | May 25, 2016 | Seres Therapeutics, Inc. | CEO | Sell | 30.0 | -9,801 | -5.07% | ✓ | $294K |
| May 6, 2016 | May 9, 2016 | Seres Therapeutics, Inc. | CEO | Sell | 22.5 | -8,507 | -27.24% | ✗ | $206.8K |
| May 4, 2016 | May 6, 2016 | Seres Therapeutics, Inc. | CEO | Sell | 17.5 | -59,325 | -39.49% | ✗ | $1.6M |
| May 2, 2016 | May 4, 2016 | Seres Therapeutics, Inc. | CEO | Sell | 17.5 | -67,367 | -34.23% | ✗ | $1.9M |
| Apr 7, 2016 | Apr 11, 2016 | Seres Therapeutics, Inc. | CEO | Sell | 20.0 | -9,212 | -28.84% | ✗ | $276.4K |
| Apr 1, 2016 | Apr 5, 2016 | Seres Therapeutics, Inc. | CEO | Sell | 17.5 | -135,788 | -34.35% | ✗ | $3.7M |